Implementation of a pharmacist-managed clinic for patients receiving erythropoietin-stimulating agents.
about
Pharmacist-managed clinics for patient education and counseling in Japan: current status and future perspectivesAssessing the quality of prescribing and monitoring erythropoiesis-stimulating agents in the nursing home setting.Staff time and motion assessment for administration of erythropoiesis-stimulating agents: a two-phase pilot study in clinical oncology practicesThe role of the pharmacist in optimizing the use of erythropoietin stimulating agents.Impact of erythropoiesis-stimulating agent prescribing at an Asian cancer center, after release of safety advisories.Incremental cost effectiveness of pharmacist-managed erythropoiesis-stimulating agent clinics for non-dialysis-dependent chronic kidney disease patients.
P2860
Implementation of a pharmacist-managed clinic for patients receiving erythropoietin-stimulating agents.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Implementation of a pharmacist ...... hropoietin-stimulating agents.
@en
Implementation of a pharmacist ...... hropoietin-stimulating agents.
@nl
type
label
Implementation of a pharmacist ...... hropoietin-stimulating agents.
@en
Implementation of a pharmacist ...... hropoietin-stimulating agents.
@nl
prefLabel
Implementation of a pharmacist ...... hropoietin-stimulating agents.
@en
Implementation of a pharmacist ...... hropoietin-stimulating agents.
@nl
P2093
P356
P1476
Implementation of a pharmacist ...... hropoietin-stimulating agents.
@en
P2093
Jamie A Bardo
Margaret M Chrymko
Stephanie E Clapp
P304
P356
10.2146/AJHP070228
P577
2008-08-01T00:00:00Z